JP2013529665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013529665A5 JP2013529665A5 JP2013517245A JP2013517245A JP2013529665A5 JP 2013529665 A5 JP2013529665 A5 JP 2013529665A5 JP 2013517245 A JP2013517245 A JP 2013517245A JP 2013517245 A JP2013517245 A JP 2013517245A JP 2013529665 A5 JP2013529665 A5 JP 2013529665A5
- Authority
- JP
- Japan
- Prior art keywords
- drospirenone
- dosage unit
- daily active
- active dosage
- contraceptive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 claims 21
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 claims 21
- 229960004845 drospirenone Drugs 0.000 claims 21
- 239000003433 contraceptive agent Substances 0.000 claims 15
- 230000002254 contraceptive effect Effects 0.000 claims 15
- 238000000034 method Methods 0.000 claims 6
- 238000004806 packaging method and process Methods 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 229940011871 estrogen Drugs 0.000 claims 4
- 239000000262 estrogen Substances 0.000 claims 4
- 239000000902 placebo Substances 0.000 claims 3
- 229940068196 placebo Drugs 0.000 claims 3
- 238000007922 dissolution test Methods 0.000 claims 2
- 235000020937 fasting conditions Nutrition 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305708 | 2010-06-29 | ||
| EP10305708.9 | 2010-06-29 | ||
| US36839610P | 2010-07-28 | 2010-07-28 | |
| US61/368,396 | 2010-07-28 | ||
| PCT/EP2011/060795 WO2012000981A1 (en) | 2010-06-29 | 2011-06-28 | Pharmaceutical composition comprising drospirenone and contraceptive kit |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013529665A JP2013529665A (ja) | 2013-07-22 |
| JP2013529665A5 true JP2013529665A5 (cg-RX-API-DMAC7.html) | 2014-07-17 |
| JP5810159B2 JP5810159B2 (ja) | 2015-11-11 |
Family
ID=42671710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517245A Active JP5810159B2 (ja) | 2010-06-29 | 2011-06-28 | ドロスピレノンを含む医薬組成物及び避妊用キット |
Country Status (25)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
| US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
| US9603860B2 (en) | 2010-07-28 | 2017-03-28 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| LT3310333T (lt) | 2015-06-18 | 2020-06-25 | Estetra Sprl | Burnoje dirperguojama vaisto formą, turinti estetrolio komponentą |
| SI3310346T1 (sl) | 2015-06-18 | 2021-07-30 | Estetra Sprl | Orodisperzibilna tableta, ki vsebuje estetrol |
| SMT201800232T1 (it) | 2015-06-18 | 2018-07-17 | Mithra Pharmaceuticals S A | Unita' di dosaggio orodispersibile contenente un componente di estetrolo |
| PT3310345T (pt) | 2015-06-18 | 2021-05-28 | Estetra Sprl | Comprimido orodispersível contendo estetrol |
| EP3108889A1 (en) | 2015-06-23 | 2016-12-28 | Philippe Perrin | Drospirenone-based contraceptive for a female patient affected with excess weight |
| EP3313408B1 (en) * | 2015-06-23 | 2023-12-06 | Laboratorios Leon Farma SA | Drospirenone-based contraceptive for a female patient affected with excess weight |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| EP4134082A1 (en) | 2021-08-12 | 2023-02-15 | Chemo Research, S.L. | Method for treating endometriosis and providing effective contraception |
| WO2023152658A1 (en) | 2022-02-10 | 2023-08-17 | Lupin Limited | Slow release drospirenone tablet composition |
| US20250186337A1 (en) | 2022-03-01 | 2025-06-12 | Chemo Research, S.L. | Chewable oral contraceptive |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2652761C2 (de) | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE3022337A1 (de) | 1980-06-11 | 1982-01-07 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen |
| JP3282731B2 (ja) | 1990-06-15 | 2002-05-20 | メルク エンド カムパニー インコーポレーテッド | 結晶の構造および大きさを改良する結晶化方法 |
| GB2256648B (en) | 1991-05-29 | 1995-08-30 | Colorcon Ltd | Wax polish composition |
| DE19633685C1 (de) | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
| US6787531B1 (en) | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| RS50262B (sr) | 1999-08-31 | 2009-07-15 | Bayer Schering Pharma Aktiengesellschaft, | Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva |
| HUP0204291A3 (en) | 2000-01-18 | 2003-05-28 | Schering Ag | Use of composition containing estrogen and drospirenone for hormone replacement therapy |
| US20020132801A1 (en) | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| US20040087563A1 (en) | 2002-11-05 | 2004-05-06 | Siegfried Mayerhofer | Hormone replacement therapy with cardiovascular protection using antialdosteronic progestins |
| US7786101B2 (en) | 2002-11-05 | 2010-08-31 | Bayer Schering Pharma Ag | Cardiovascular protection using anti-aldosteronic progestins |
| MY142989A (en) | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
| DK1748756T3 (da) | 2004-03-10 | 2009-06-15 | Bayer Schering Pharma Ag | Præparater som omfatter drospirenon der er molekylært dispergeret |
| US20050220825A1 (en) | 2004-03-10 | 2005-10-06 | Adrian Funke | Molecular dispersions of drospirenone |
| MY151322A (en) | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| CA2571377C (en) | 2004-07-07 | 2014-03-25 | Wyeth | Cyclic progestin regimens and kits |
| EP1625849A1 (en) | 2004-08-09 | 2006-02-15 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical composition comprising drospirenone and ethynylestradiol |
| ITMI20042338A1 (it) | 2004-12-06 | 2005-03-06 | Ind Chimica Srl | Processo per la preparazione di drospirenone |
| US20060293295A1 (en) | 2005-05-13 | 2006-12-28 | Kai Strothmann | Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate |
| US8475838B2 (en) | 2005-06-03 | 2013-07-02 | Sandoz Ag | Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| TW200727920A (en) | 2005-06-21 | 2007-08-01 | Organon Nv | New regimens for oral monophasic contraceptives |
| DK1746101T4 (da) | 2005-07-21 | 2014-08-11 | Bayer Pharma AG | Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner |
| CN101489563A (zh) | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | 用于避孕和预防先天性畸形风险的药物制剂 |
| EP2063870A2 (en) * | 2006-09-16 | 2009-06-03 | Bayer Schering Pharma Aktiengesellschaft | Oral modified release formulations |
| AR066166A1 (es) | 2007-09-21 | 2009-07-29 | Organon Nv | Sistema de suministro de droga |
| BRPI0908231A2 (pt) | 2008-02-13 | 2015-07-21 | Bayer Schering Pharma Akltiengesellschaft | Sistema de liberação de fármaco com efeito estabilizante |
| WO2009138224A1 (en) * | 2008-05-14 | 2009-11-19 | Helm Ag | Pharmaceutical composition comprising drospirenone |
| TW201008569A (en) * | 2008-08-08 | 2010-03-01 | Bayer Schering Pharma Ag | Progestin-containing drug delivery system |
| DE102008037025C5 (de) | 2008-08-08 | 2016-07-07 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform |
| AR081670A1 (es) * | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
| US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
| US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| US9603860B2 (en) | 2010-07-28 | 2017-03-28 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
-
2011
- 2011-06-27 AR ARP110102229A patent/AR081670A1/es not_active Application Discontinuation
- 2011-06-28 PH PH1/2012/502499A patent/PH12012502499A1/en unknown
- 2011-06-28 RS RS20200081A patent/RS59826B1/sr unknown
- 2011-06-28 EP EP11727985.1A patent/EP2588114B1/en active Active
- 2011-06-28 HR HRP20220332TT patent/HRP20220332T1/hr unknown
- 2011-06-28 PL PL11727985T patent/PL2588114T3/pl unknown
- 2011-06-28 KR KR1020217002806A patent/KR102539030B1/ko active Active
- 2011-06-28 SI SI201132044T patent/SI3632448T1/sl unknown
- 2011-06-28 ES ES19209672T patent/ES2908657T3/es active Active
- 2011-06-28 SM SM20200063T patent/SMT202000063T1/it unknown
- 2011-06-28 KR KR1020177019333A patent/KR102164693B1/ko active Active
- 2011-06-28 EA EA201291372A patent/EA028680B1/ru unknown
- 2011-06-28 PL PL19209672T patent/PL3632448T3/pl unknown
- 2011-06-28 BR BR112012033391-7A patent/BR112012033391B1/pt active IP Right Grant
- 2011-06-28 EP EP19209672.5A patent/EP3632448B1/en active Active
- 2011-06-28 CA CA3061421A patent/CA3061421C/en active Active
- 2011-06-28 CA CA2803721A patent/CA2803721C/en active Active
- 2011-06-28 HU HUE19209672A patent/HUE058176T2/hu unknown
- 2011-06-28 RS RS20220179A patent/RS63027B1/sr unknown
- 2011-06-28 NZ NZ605176A patent/NZ605176A/en unknown
- 2011-06-28 WO PCT/EP2011/060795 patent/WO2012000981A1/en not_active Ceased
- 2011-06-28 LT LTEP19209672.5T patent/LT3632448T/lt unknown
- 2011-06-28 PE PE2012002518A patent/PE20130780A1/es active IP Right Grant
- 2011-06-28 PT PT192096725T patent/PT3632448T/pt unknown
- 2011-06-28 EP EP22150746.0A patent/EP4056186A1/en active Pending
- 2011-06-28 SI SI201131838T patent/SI2588114T1/sl unknown
- 2011-06-28 KR KR1020137001350A patent/KR20130048227A/ko not_active Ceased
- 2011-06-28 SM SM20220129T patent/SMT202200129T1/it unknown
- 2011-06-28 CA CA3003062A patent/CA3003062C/en active Active
- 2011-06-28 JP JP2013517245A patent/JP5810159B2/ja active Active
- 2011-06-28 DK DK19209672.5T patent/DK3632448T3/da active
- 2011-06-28 PE PE2016002187A patent/PE20161410A1/es unknown
-
2020
- 2020-02-03 CY CY20201100088T patent/CY1122544T1/el unknown
- 2020-06-11 NO NO2020015C patent/NO2020015I1/no unknown
- 2020-06-11 HU HUS2000016C patent/HUS2000016I1/hu unknown
- 2020-06-11 FR FR20C1020C patent/FR20C1020I1/fr active Active
-
2022
- 2022-03-10 CY CY20221100198T patent/CY1125061T1/el unknown
- 2022-04-11 US US17/717,550 patent/US11452695B2/en active Active
- 2022-05-10 HU HUS2200018C patent/HUS2200018I1/hu unknown
- 2022-06-22 LT LTPA2022513C patent/LTPA2022513I1/lt unknown
- 2022-06-23 FR FR22C1031C patent/FR22C1031I2/fr active Active
- 2022-06-29 US US17/853,623 patent/US11478487B1/en active Active
- 2022-06-30 US US17/855,432 patent/US11491113B1/en active Active
- 2022-07-01 US US17/856,605 patent/US11504334B2/en active Active
- 2022-07-11 NO NO2022030C patent/NO2022030I1/no unknown
- 2022-10-17 US US17/967,767 patent/US12090231B2/en active Active
-
2023
- 2023-08-04 US US18/365,877 patent/US11951213B2/en active Active
-
2024
- 2024-07-05 US US18/765,167 patent/US12280151B2/en active Active
-
2025
- 2025-03-20 US US19/085,343 patent/US20250213488A1/en active Pending
- 2025-03-20 US US19/085,309 patent/US20250213487A1/en active Pending